中国P站

ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentary   
  • J Alzheimers Dis Parkinsonism, Vol 15(3)
  • DOI: 10.4172/2161-0460.1000641

Understanding the Causes of Parkinson’s Disease

Diego Alvarez*
*Corresponding Author: Diego Alvarez, Department of Neuroscience, Colombia University, Colombia, alvarezdiego19@outlook.com

Received: 12-Aug-2024 / Manuscript No. JADP-24-145125 / Editor assigned: 15-Aug-2024 / PreQC No. JADP-24-145125 (PQ) / Reviewed: 31-Aug-2024 / QC No. JADP-24-145125 / Manuscript No. JADP-24-145125 (R) / Published Date: 20-Jun-2025 DOI: 10.4172/2161-0460.1000641

Introduction

Parkinson’s Disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor symptoms such as tremor, rigidity, bradykinesia, and postural instability. Discovered by James Parkinson in 1817, the disease has since been the subject of extensive scientific investigations. Despite significant advancements in understanding its pathology, the exact causes of Parkinson’s remain elusive. This short communication aims to summarize current knowledge on the various factors contributing to the onset and progression of Parkinson’s disease, including genetic, environmental, and lifestyle influences.

Genetic factors

A small percentage of Parkinson’s cases can be attributed to mutations in specific genes. These include:

SNCA (α-synuclein): Mutations and multiplications of this gene lead to the production of abnormal α-synuclein protein, a major component of Lewy bodies found in Parkinsonian brains.

LRRK2 (Leucine-Rich Repeat Kinase 2): Mutations in this gene are the most common genetic cause of familial and sporadic Parkinson’s disease, affecting various cellular processes.

Parkin, PINK1, and DJ-1: These genes are associated with earlyonset Parkinson’s and are involved in mitochondrial function and protection against oxidative stress. Beyond monogenic forms, several risk loci identified through Genome-Wide Association Studies (GWAS) contribute to a polygenic risk for Parkinson’s. These include variants in genes such as GBA (Glucocerebrosidase), MAPT (Microtubule- Associated Protein Tau), and BST1 (Bone marrow Stromal Cell antigen 1). These variants, individually, confer a modest increase in risk but collectively may have a significant impact on susceptibility to the disease.

Environmental factors

Environmental toxins have long been implicated in the etiology of Parkinson’s disease. Chemicals such as paraquat and rotenone have been linked to an increased risk of Parkinson’s. These substances can induce oxidative stress and mitochondrial dysfunction, contributing to dopaminergic neuron degeneration. Exposure to heavy metals like manganese and lead has been associated with Parkinsonian symptoms. These metals can accumulate in the brain and disrupt normal neuronal function. Epidemiological studies have shown a higher incidence of Parkinson’s in rural areas and among individuals consuming well water. This is believed to be due to increased exposure to agricultural chemicals and potential contamination of groundwater with neurotoxic substances.

Diet and nutrition

Dietary habits can influence the risk of developing Parkinson’s: Diets rich in antioxidants, such as those containing high levels of fruits, vegetables, and certain vitamins (e.g., vitamin E), may offer some protection against Parkinson’s by combating oxidative stress. Some studies suggest a higher risk of Parkinson’s associated with increased consumption of dairy products, potentially due to contaminants or components in dairy that affect dopaminergic neurons.

Physical activity

Regular physical activity has been shown to reduce the risk of Parkinson’s. Exercise promotes neuroplasticity, enhances mitochondrial function, and reduces inflammation, which may collectively protect against neurodegeneration.

Oxidative stress

Oxidative stress is a central mechanism in Parkinson’s disease pathogenesis. The imbalance between the production of Reactive Oxygen Species (ROS) and the body’s ability to detoxify these reactive intermediates leads to cellular damage. Dopaminergic neurons in the substantia Nigra are particularly vulnerable due to their high metabolic rate and dopamine metabolism, which generates ROS.

Mitochondrial dysfunction

Mitochondrial dysfunction is another critical factor in Parkinson’s. Mitochondria are responsible for energy production, and their impairment leads to energy deficits and increased ROS production. Mutations in genes such as PINK1 and Parkin, which are involved in mitochondrial quality control, further highlight the importance of mitochondrial integrity in preventing neurodegeneration.

Protein aggregation

The aggregation of misfolded proteins, particularly α-synuclein, into Lewy bodies is a hallmark of Parkinson’s disease. These aggregates can disrupt cellular functions, including synaptic transmission and protein degradation pathways. The spread of α-synuclein pathology from cell to cell also suggests a prion-like mechanism of disease propagation.

Conclusion

The causes of Parkinson’s disease are multifactorial, involving a complex interplay between genetic predisposition, environmental exposures, and lifestyle factors. While significant progress has been made in identifying genetic mutations and environmental toxins linked to the disease, much remains to be understood about their interactions and the underlying mechanisms leading to neuronal degeneration. Future investigations should focus on elucidating these complex relationships and developing targeted interventions to prevent and treat Parkinson’s disease. Enhanced understanding of these factors will pave the way for personalized medicine approaches, offering hope for improved outcomes for those affected by this debilitating condition.

Citation: Alvarez D (2025) Understanding the Causes of Parkinson’s Disease. J Alzheimers Dis Parkinsonism 15: 641. DOI: 10.4172/2161-0460.1000641

Copyright: © 2025 Alvarez D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Tools
Article Usage
  • Total views: 240
  • [From(publication date): 0-0 - Apr 06, 2026]
  • Breakdown by view type
  • HTML page views: 162
  • PDF downloads: 78
International Conferences 2026-27
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top Connection closed successfully.